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Chemical’s persistence is known to be an important parameter applied for decades to identify persistent
organic pollutants in hazard and/or risk assessments. Nevertheless it is greatly challenged in the case of
emerging contaminants such as pharmaceuticals because the persistence of these chemicals could be
more affected by environmental conditions. This fact brings more challenges to the current system for
evaluating the persistence of chemical contaminants. In this paper, challenges in assessing the persis-
tence of pharmaceuticals were identiﬁed, and more importantly research needs were addressed based on
the existing data and knowledge.
Copyright © 2016, KeAi Communications Co., Ltd. Production and hosting by Elsevier B.V. on behalf of
KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chemical’s persistence is deﬁned by its ability to retain in the
environment, which is an important parameter applied for decades
to identify persistent organic pollutants (POPs) or persistent, bio-
accumulative and toxic (PBT) chemicals. One of the well-known
practices is that the persistence attribute is employed as one of
the most important parameters in Stockholm Convention for
selecting POP candidates. The criteria for chemical persistence have
been established under many regulatory frameworks to select
chemicals of concern based on their transformation half-lives in the
individual medium such as air, water, soil and sediment. For
instance, both United Nations Environmental Program and Cana-
dian Environmental Protection Agency set half-lives of 60 and 180
days as the criterion for chemical persistence in water and soil,
respectively [1,2]. The above criteria have been demonstrated to be
effective during screening of traditional POPs or PBT chemicalsonmental Engineering, China
R China.
Tsinghua University, Beijing
Bu), yg-den@tsinghua.edu.cn
nications Co., Ltd.
o., Ltd. Production and hosting by E
ons.org/licenses/by-nc-nd/4.0/).[3,4].
Persistence is usually assessed as an inherent property of a
chemical [3] by using the well-established test guidelines in the lab
[5e7]. By contrast, as the quantitative measure of persistence,
transformation half-life of a chemical in the environment could be
contributed by diverse processes, such as hydrolysis, biodegrada-
tion, direct or indirect photolysis, redox reactions. These processes
are highly dependent on environmental conditions, e.g. tempera-
ture, salt, redox status, microorganism activity, and sunlight
exposure [8]. Thus, the transformation half-life of a chemical in the
environment is determined by a combination of chemical-speciﬁc
characteristics and environmental conditions.
The traditional POPs regulated under Stockholm Convention are
usually inherently persistent, as they are stable and cannot be
transformed easily unless under strong artiﬁcial conditions [9e17].
Thus, the persistence of these chemicals in the environment is
more dependent on its intrinsic properties. However, for some
emerging contaminants that are not as persistent as traditional
POPs, the persistence may be more affected by environmental
conditions. And it is hard for scientists and managers to accurately
quantify the transformation rates of a chemical in the environment
and further to judge the persistence by using the lab test of
persistence.
Pharmaceuticals are among these chemicals that the trans-
formation could depend to a large extent on environmental con-
ditions [18]. While the widespread presence of pharmaceuticals inlsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article
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last two decades [19e23], limited knowledge on their environ-
mental fate (e.g. persistence) is available now. In this paper, we seek
to address the challenges and needs in assessing the persistence of
pharmaceuticals by comparing existing persistence data obtained
both in the ﬁled and the lab. To this end, a brief overview of the
persistence data was conducted and we found that few pharma-
ceuticals were investigated for their persistence properties. Three
of them (i.e. carbamazepine, diclofenac and ibuprofen) were in
accordance with the aim of the present study. Although during
recent years related studies on the fate of pharmaceuticals in other
matrices, for example soils [24,25], are increasing, the data were
still limited to make the comparison. Thus at now we focused on
persistence studies for pharmaceuticals in the aquatic environ-
ment, because these chemicals are mostly polar ones and emitted
with the discharge of wastewater as water-borne contaminants.We
hope this paper will be a turning point for assessing the persistence
of pharmaceuticals in the environment on a sound basis.2. Persistence of pharmaceuticals in the aquatic environment
Persistence could be inferred from the continuous presence of a
chemical in the environment distant from the emission source
through long-term monitoring or biomonitoring. However, this
may not apply for pharmaceuticals in environments. Pharmaceu-
ticals were frequently detected with high residue concentrations in
the aquatic environment, probably due to their continuous emis-
sion from sewage treatment plants which is signiﬁcantly faster
than their environmental removal rates. In view of this, pharma-
ceuticals were considered as a group of pseudo-persistent con-
taminants [26].
Another popular evidence for persistence screening is the slow
rate of transformation in the laboratory simulation tests or ﬁeld
studies with good designs (that is preferred). Table 1 lists the
degradation half-lives of three well studied pharmaceuticals in the
aquatic environment or water-sediment systems, including carba-
mazepine, diclofenac and ibuprofen. The difference of betweenTable 1
Persistence, expressed as transformation half-life in the aquatic environment or water-s
Pharmaceuticals Test type Half-life, days Date
Carbamazepine Lab 3.5a August, 2006
Lab 88a May, 2007
Lab 125b September, 2006
Lab 233b October, 2007
Field 63 August-Septembe
Field 1200 Spring, 2013
Diclofenac Lab 0.008a July, 1999
Field <30 February, 1998
Field <8 October, 1997
Field 8 August-Septembe
Field 10 Spring, 2013
Field 21 Late spring, 2013
Ibuprofen Lab 25a August, 2006
Lab 413a May, 2007
Lab 19b September, 2006
Lab 20b October, 2007
Field 4.6 September, 2005
Field 32 August-Septembe
Field <5.6 Late spring, 2013
Field <27 Late autumn, 2013
Field <7.2 Early winter, 2013
a Photolysis half-life.
b Biodegradation half-life.
c The location denotes where the test chemicals exposed to sunlight.
d The location denotes where the test water sampled.half-lives obtained in the lab and the ﬁeld is striking. The variations
of these observed values with location and time (or season) are
worthy to note. For carbamazepine, most evidence either obtained
in the lab or the ﬁeld showed its half-life exceeded the persistence
criteria of 60 days in waters. However, the long half-life of 1200
days observed by Zou et al. [27] in the ﬁeld is remarkable and re-
quiresmore attention. Vice versa the extremely fast photolysis with
half-life of 3.5 days observed in the lab is impressive [28]. All of the
investigated half-lives indicated that diclofenac is not persistent in
the environment, although the observed values of half-life vary
between studies. Yamamoto et al. [28] reported a surprisingly
prolonged photolysis half-life of 413 days for ibuprofen, while most
studies showed that ibuprofen with half-life shorter than the
persistence threshold.3. Challenges and research needs
As important human beneﬁts, the use and subsequent release of
pharmaceuticals are unavoidable to the environment. Hence there
are increasing concerns about the presence of pharmaceuticals in
environments, and assessing the persistence of these active phar-
maceutical ingredients is among the most important issues for
understanding their environmental fate. Here the challenges and
research needs were identiﬁed according to the available infor-
mation at present.
On the one hand, signiﬁcant difference is observed for values of
half-life obtained in lab simulation tests from ﬁeld studies (Table 1),
which will challenge the extrapolation of half-life from the lab to
the ﬁeld. To address this challenge, the following studies should be
of need. (1) It is of great importance to develop sophisticated
methods for determining the persistence of pharmaceuticals (or
chemicals) in the ﬁeld, which is the ﬁrstly important step for ac-
curate quantiﬁcation of persistence and further assessing the pos-
sibility of extrapolation of half-life from the lab to the ﬁeld. Using
themass balancemodel in awell-deﬁned river or lake system is one
of the most important approaches for determining persistence in
the ﬁeld and was well documented [29e31,33e37]. Most studiesediment systems for three well-studied pharmaceuticals.
Locations References
Tokushima, Japanc Yamamoto et al. [28]
Tokushima, Japanc Yamamoto et al. [28]
Tamiya River, Japand Yamamoto et al. [28]
Tsumeta River, Japand Yamamoto et al. [28]
r, 1999 Lake Greifensee, Switzerland Tixer et al. [29]
Lake Norra Bergundasj€on, Sweden Zou et al. [27]
W€adenswil, Switzerlandc Poiger et al. [30]
Lake Greifensee, Switzerland Buser et al. [31]
Lake Greifensee, Switzerland Buser et al. [31]
r, 1999 Lake Greifensee, Switzerland Tixer et al. [29]
Lake Norra Bergundasj€on, Sweden Zou et al. [27]
Lake Boren, Sweden Zou et al. [32]
Tokushima, Japanc Yamamoto et al. [28]
Tokushima, Japanc Yamamoto et al. [28]
Tamiya River, Japand Yamamoto et al. [28]
Tsumeta River, Japand Yamamoto et al. [28]
Trinity River, USA Fono et al. [33]
r, 1999 Lake Greifensee, Switzerland Tixer et al. [29]
Lake Boren, Sweden Zou et al. [32]
Lake Boren, Sweden Zou et al. [32]
Lake Boren, Sweden Zou et al. [32]
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state, while chemical ﬂows in the real environment are largely time
dependent, especially for pharmaceuticals [38e40]. To overcome
the problems of spatial and temporal variability, Zou et al.
[18,27,32] developed and applied a framework by using the tech-
nique of chemical benchmarking. Nonetheless, it is difﬁcult to
select proper benchmark chemicals for pharmaceuticals with
varying emission patterns in reality. Thus, a dynamic mass balance
model would be just the foundation and research need for the
future development of methods of determining the persistence in
the ﬁeld. Once one can measure the persistence in the ﬁeld accu-
rately, (2) comparing the persistence determined in lab tests with
that measured in the ﬁeld will be possible, and further the possi-
bility of lab-to-ﬁeld extrapolation should be assessed.
Another challenge is due that the persistence of pharmaceuti-
cals varies with time and location (Table 1). This is easy to under-
stand as many factors inﬂuencing the persistence are time or
location dependent, for example, the diversity of microorganisms
among different locations, in the case of biodegradation. As a result,
(1) it emphasized the need of determining the temporal and spatial
variation of persistence in the real environment, as they may be
different location from location even in the same river [41]; Based
on the results, (2) the inﬂuence mechanism of environmental
conditions on persistence of pharmaceuticals should be classiﬁed,
which is also important for establishing the lab-to-ﬁeld extrapo-
lation method in the future; and (3) since pharmaceuticals (as well
for other chemical contaminants) display a distribution of persis-
tence (expressed as half-life) as a function of time and location, the
traditional pass-fail system based on a “single cut-off line” is
ﬂawed. There is a need of setting new criteria for judging the
persistence in the environmental reality. A possible solution is to
compare the persistence with cut-off values based on a probability
distribution curve.
Moreover the continued presence of pharmaceuticals in the
aquatic environment could be explained by the continuous release
or the inherent persistence, which also challenges the traditional
regulatory actions for these chemicals. Hence efforts on differen-
tiating the reason for their continuous presence in the environment
are welcomed. This will result in completely different actions for
contamination control. For example, for a pharmaceutical with
large use volume but fast transformation, the control actions
should include avoiding abuse (e.g. the case of antibiotics), proper
disposal of unused drugs and so on. For pharmaceuticals that are
inherently hard to degrade, search for alternatives would be part of
the choices.
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